What is the catalog number for Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody?

The catalog number for Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody is orb76087.

What sizes are available for Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody?

Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody in stock?

Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Eph receptor A1/EPHA1 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Ephrin type-A receptor 1; hEpha1; 2.7.10.1; EPH tyrosine kinase; EPH tyrosine kinase 1; Erythropoietin-producing hepatoma receptor; Tyrosine-protein kinase receptor EPH; EPHA1; EPH, EPHT, EPHT1

UniProt

P21709

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human Eph receptor A1, identical to the related rat and mouse sequences.

Target

Ephrin type-A receptor 1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cardiovascular Research, Neuroscience, Protein Biochemistry, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Rat, Mouse Western blot, 0.1-0.5μg/ml, Human, Rat, Mouse

Form

Lyophilized

Molecular Weight

113 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.